Error: Could not add to watchlist. X
+ Watchlist

ARIAD Pharmaceuticals Inc

ARIA:US
Acquired
ARIA:US was acquired by 4502:JP
USD
Volume
0
52Wk Range
7.89 - 23.99
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
52Wk Range
7.89 - 23.99
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.59
Market Cap (USD)
-
Shares Outstanding (m)
194.201
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.06%
% Price Change
+0.10%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
ARIAD Pharmaceuticals, Inc. is a global oncology company focused on the discovery, development and commercialization of medicines to transform the lives of cancer patients. The Company's approach to structure-based drug design has led to several molecularly targeted medicines for drug-resistant or difficult-to-treat cancers.
Address
26 Landsdowne Street
Cambridge, MA 02139-4234
United States
Phone
1-617-494-0400
Show More